Double-blind Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of Intermittent, Long-term Administration of Levosimendan in Patients With Advanced Heart Failure.

Trial Profile

Double-blind Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of Intermittent, Long-term Administration of Levosimendan in Patients With Advanced Heart Failure.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2015

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms LAICA
  • Most Recent Events

    • 12 Dec 2015 Status changed from recruiting to discontinued, according to European Clinical Trials Database record.
    • 17 Sep 2013 Planned end date changed from 21 Sep 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 17 Jan 2012 Planned End Date changed from 1 Nov 2011 to 21 Sep 2013.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top